These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 10958312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, Hoshi M, Miyamoto S.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [Abstract] [Full Text] [Related]

  • 3. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY, Asari T, Hamada N, Makino F, Ishikawa N, Abe Y, Ito K, Ito K.
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
    Ishii R, Imaizumi M, Ide A, Sera N, Ueki I, Horie I, Ando T, Usa T, Ejima E, Ashizawa K, Eguchi K.
    Endocr J; 2010 May; 57(1):73-9. PubMed ID: 19851036
    [Abstract] [Full Text] [Related]

  • 8. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M, Seki T, Ozawa H, Ishihara T, Komatsu M, Tajiri S, Yanagi H, Nishina M, Noh JY, Fukagawa M, Takagi A.
    Endocr J; 2013 May; 60(3):383-8. PubMed ID: 23154533
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
    Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W, Chuansumrit A, Chunharas A.
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
    [Abstract] [Full Text] [Related]

  • 11. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
    Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
    Kawasaki Y, Suzuki J, Sike T, Isome M, Nozawa R, Suzuki S, Kume K, Suzuki H.
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
    Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S.
    Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
    [Abstract] [Full Text] [Related]

  • 15. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
    Yang J, Yao LP, Dong MJ, Xu Q, Zhang J, Weng WW, Chen F.
    Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
    [Abstract] [Full Text] [Related]

  • 16. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil.
    Yamashita Y, Yamane K, Fujikawa R, Okubo M, Kohno N.
    Endocr J; 2002 Oct; 49(5):555-9. PubMed ID: 12507274
    [Abstract] [Full Text] [Related]

  • 17. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole.
    Gumà M, Salinas I, Reverter JL, Roca J, Valls-Roc M, Juan M, Olivé A.
    J Clin Endocrinol Metab; 2003 May; 88(5):2141-6. PubMed ID: 12727967
    [Abstract] [Full Text] [Related]

  • 18. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
    Guo XH, Zhao MH, Gao Y, Wang SF, Gao Y.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):932-5. PubMed ID: 12899790
    [Abstract] [Full Text] [Related]

  • 19. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
    Morais P, Baudrier T, Mota A, Cunha AP, Alves M, Neves C, Capela J, Sá-Couto P, Azevedo F.
    Cutan Ocul Toxicol; 2011 Jun 10; 30(2):147-53. PubMed ID: 21091384
    [Abstract] [Full Text] [Related]

  • 20. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
    Xu X, Zhao M, Zhang Y, Guo X, Wang H.
    Zhonghua Nei Ke Za Zhi; 2002 Jun 10; 41(6):404-7. PubMed ID: 12137604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.